Cisplatin and aki and autophagy
WebJan 10, 2024 · Cisplatin, a chemotherapeutic agent approved by the United States Food and Drug Administration in 1978, is used in the treatment of various solid organ malignancies [ 13 ]. However, ~30% of... WebCisplatin, a chemotherapeutic agent, is a known nephrotoxin and can cause AKI. The cisplatin treatment induces a time-dependent increase in the LC3 expression in proximal tubular epithelial cells. 23 The inhibition of autophagy through either treatment with 3-MA or knockdown of Becn1 by short-hairpin RNA or siRNA, or Atg5 by siRNA resulted in ...
Cisplatin and aki and autophagy
Did you know?
WebMar 23, 2024 · Here, we postulated that systemically delivered rapamycin perfluorocarbon nanoparticles (PFC NP) could reach the injured kidneys at sufficient and sustained concentrations to mitigate cisplatin-induced acute kidney injury and preserve renal function. Using fluorescence microscopic imaging and fluorine magnetic resonance … WebApr 27, 2024 · Aims:Cisplatin, an anticancer drug, always leads to nephrotoxicity by causing mitochondrial dysfunction. As a major mechanism for cellular self-degradation, autophagy has been proven to protect against cisplatin …
WebNov 30, 2024 · In this study, we investigated whether canagliflozin protects against cisplatin-induced AKI, depending on adenosine monophosphate-activated protein kinase (AMPK) activation and following... WebDec 12, 2024 · Cisplatin can induce AKI through ischemic damage, by reducing the blood flow in the medulla of the kidneys leading to tubular cell injury. Vasoconstriction due to …
WebApr 6, 2024 · Therefore, it is particularly important to find drugs that have therapeutic effect against cisplatin ototoxicity. Autophagy is a cell metabolic process in which cells degrade their components within lysosomes (or vacuoles) to maintain normal physiological activities and homeostasis ( 7 ). WebApr 25, 2014 · The role of autophagy in cisplatin-induced AKI is discussed in the next section. 4.2. Autophagy Autophagy is a cellular process of “self-eating” in which …
WebDec 31, 2024 · Special Issue Information. Dear Colleagues, Autophagy (“auto-digestion”), a lysosome-dependent process, degrades and turnovers damaged or senescent organelles and proteins. Autophagy is a highly-regulated process, which impacts several vital cellular responses, including inflammation, cell death, energy metabolism and organelles ...
WebFeb 18, 2024 · Cisplatin, a platinum-based compound, is a commonly used and highly effective chemotherapeutic agent utilized for the treatment of a variety of solid tumors. … sharma goldson ze li and alexander taamWeb1 day ago · In this study, a natural product from Osage Orange, pomiferin, was identified as a novel autophagy activator that circumvents innate resistance by triggering autophagic cell death via SERCA inhibition and activation of the CaMKKβ-AMPK-mTOR signaling cascade. In addition, pomiferin also directly inhibited the P-gp (MDR1/ABCB1) efflux and ... population of jackson ms 2022WebSep 1, 2014 · Pharmacologic induction of autophagy by administrating the mTOR inhibitor, rapamycin or temsirolimus, facilitated renal recovery from AKI during endotoxemia in aged mice [116,119] and pharmacologic inhibition of autophagy with either bafilomycin or 3-methyladenine enhanced cisplatin-induced renal tubular cell death . sharma graphicsWebAdministration of the chemotherapeutic agent cisplatin leads to acute kidney injury (AKI). Cisplatin-induced AKI (CIAKI) has a complex pathophysiological map, which has been … population of jackson holeWebOct 14, 2024 · Cisplatin is an inorganic platinum-based drug that was FDA approved as an anticancer agent in 1978.1It is a standard therapy used to treat many solid organ … sharma group vicenzaWebCisplatin-induced acute kidney injury in mice was established by intraperitoneal injection of cisplatin. The levels of urea nitrogen and creatinine in serum were measured, renal pathology change was assayed by HE staining, qRT-PCR and Western blot were used to detect the expression levels of PIM1 mRNA and PIM1 protein. sharma gold melbourneWebNov 1, 2024 · Toll‐like receptor 2 (TLR2) is constitutively expressed in tubular epithelial cells of the kidney and participates in cisplatin‐induced AKI. The autophagy is a dynamic catabolic process that maintains intracellular homeostasis, which is involved in the pathogenesis of AKI. sharma group world wide srl